MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • 2023 International Congress

    Testing the applicability of the dysarthria analyzer to detect levodopa effects on speech in a German cohort of people with Parkinson’s disease

    T. Thies, J. Schreen, H. Jergas, M. Barbe (Cologne, Germany)

    Objective: To test the applicability of “the dysarthria analyzer” in a levodopa challenge test to determine short term effects of levodopa on acoustic speech parameters.…
  • 2023 International Congress

    Speech, gait and vestibular instrumental assessment in CANVAS: a case series.

    G. Di Rauso, F. Cavallieri, V. Fioravanti, E. Monfrini, A. Gessani, I. Campanini, A. Merlo, A. Castellucci, D. Ronchi, M. Napoli, R. Pascarella, S. Grisanti, R. Sabadini, C. Zini, A. Di Fonzo, F. Valzania (Modena, Italy)

    Objective: To describe through a systematic clinical-instrumental approach speech, gait and vestibular alterations in cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Background: CANVAS…
  • 2023 International Congress

    Effectiveness of speech therapy in patients with Parkinson’s disease – a randomized controlled trial

    J. Maas, N. de Vries, B. Bloem, H. Kalf (Nijmegen, Netherlands)

    Objective: We aimed to assess the effectiveness of speech therapy on improving quality of life and speech quality in patients with Parkinson’s disease. Background: Although…
  • 2023 International Congress

    Analysis of the relationship between acoustic measures and VHI score

    Y. Manor, Y. Kochetkov, Y. Hauptman, D. Shpunt, A. Zait, T. Gurevich (Tel Aviv, Israel)

    Objective: To examine whether there is a relationship between acoustic measurements extracted from audio recordings of sustained vowel /a/ of PWP and their VHI scores.…
  • 2023 International Congress

    An acoustic-perceptual analysis of speech in clinical PSP phenotypes.

    G. Di Rauso, F. Cavallieri, A. Gessani, D. Fontanesi, S. Coniglio, V. Fioravanti, S. Contardi, E. Menozzi, S. Meletti, F. Antonelli, V. Rispoli, F. Valzania, C. Budriesi (Modena, Italy)

    Objective: To examine the speech profile in a cohort of patients with Progressive Supranuclear Palsy with Richardson’s syndrome (PSP-RS) and PSP with predominant parkinsonism (PSP-P)…
  • 2023 International Congress

    SpeechATAX: A rater blinded randomized controlled trial of intensive home-based biofeedback therapy for dysarthria in progressive ataxia

    A. Vogel, L. Graf, H. Reece, M. Magee, V. Soo, S. Braat, E. Petit, S. Borel, A. Durr, R. Roxburgh, M. Synofzik (Melbourne, Australia)

    Objective: To investigate the effectiveness of a digitized intensive home-based speech rehabilitation, SpeechATAX, in people with progressive hereditary ataxia. Background: The loss of the ability…
  • 2022 International Congress

    The Effect of a Boxing Exercise Program on Laryngeal Function in People with Parkinson’s Disease

    Z. Thijs, C. Watts (Fort Worth, USA)

    Objective: This project aimed to determine the effect of a boxing exercise program on aerodynamic measures related to voice production (maximum expiratory pressure, MEP; transglottal…
  • 2022 International Congress

    Feasibility of telephonic voice samples to remotely monitor people with Parkinson’s disease residing in medically underserved rural regions

    A. Kemp, A. Iyer, A. Glover, L. Pillai, P. Farmer, Y. Rahmatallah, S. Syed, M. Lotia, L. Larson-Prior, F. Prior, T. Virmani (Little Rock, USA)

    Objective: To explore the feasibility of collecting voice samples using digital voicemail in People with Parkinson’s disease (PwPD). Background: For many PwPD, the increased adoption…
  • 2022 International Congress

    Multicentric prospective study of subthalamic deep brain stimulation 1-year impact on speech in Parkinson’s disease

    T. Ollivier (Lille, France)

    Objective: 1) To describe the evolution of speech in a large cohort of patients before and 1 year after STN-DBS (subthalamic deep brain stimulation). 2)…
  • 2022 International Congress

    Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: the PD COMM randomised controlled trial.

    C. Sackley, C. Rick, S. Patel, R. Woolley, M. Brady, A. Nicoll, S. Dickson, G. Beaton, C. Smith, H. Nankervis, C. Burton, P. Masterson-Algar, N. Ives, S. Jowett, Z. Abdali, L. Sharp, T. Jeffreys, C. Clarke (London, United Kingdom)

    Objective: To evaluate the clinical effectiveness of two speech and language therapy (SLT) approaches compared to no SLT (control) for people with Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 18
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley